Innova Partnerships' Investment, Imhanz Ltd, Acquired by Mohn Aqua Group
Sep 05, 2015
Innova Partnerships' portfolio investment company, Imhanz Ltd, has been acquired by the Mohn Technology Ltd, part of the Mohn Aqua group.
Imhanz was formed in November 2013 and has since developed their technology and expertise in image management and processing for application in the $185 billion global aquaculture market. The unique technologies and capabilities of the Imhanz team attracted interest and subsequent acquisition of the company by Mohn Aqua Group who develop technology solutions for this market.
The Mohn Aqua Group consists of three companies at present - Mohn Aqua Group AS and Mohn Aqua (Norge) AS in Norway and Mohn Aqua (UK) Ltd in the UK. With bases in Bergen, Norway and Forres, Scotland, the company is a world leader in supplying technology solutions to the aquaculture industry.
Innova Partnerships worked with Dr Ross Maxwell on the development of Imhanz, mentoring and advising the Company through initial development phases and assisting the eventual sale of Imhanz Ltd to the Mohn Aqua Group.
CEO Professor Steve Howell commented, “We are delighted to see the acquisition of Imhanz Ltd by the Mohn Aqua Group. The team have developed world class technologies which can be deployed in a range of applications for the growing aquaculture market".
At Innova Partnerships this represents the first exit from our own portfolio of investment companies and we anticipate building on this as other companies we have invested in continue to grow and develop. We look forward to the continued development and success of the Imhanz team as part of the Mohn Aqua Group.”
Biotangents; Primed for Success
- Oct 19, 2017
Dr Andrew McNair Appointed as Innova Partnerships Managing Director
- Jul 21, 2017
Innova Partnerships Exits Portfolio Company: Innova Biosciences Acquired by SYGNIS AG
- Jun 21, 2017
Portfolio Company, Relaymed, Signs Strategic Alliance with Siemens Healthineers to Seamlessly Deliver Point-of-Care Test Results to HER Systems
- May 18, 2017
Portfolio Company, Innova Biosciences, valued at €12.8 Million to be Acquired by Sygnis AG
- May 08, 2017